Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPN1 | P15169 | 2/20 | 0.35 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | TMPRSS15 | P98073 | 1/20 | 0.31 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.30 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.30 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.30 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8752967 | 0.84 | ALDH1A1 (0.31) | PTGS1SLC7A11 | |
| SCHEMBL9410679 | 0.84 | ALDH1A1 (0.31) | PTGS1SLC7A11 | |
| SCHEMBL9410676 | 0.84 | ALDH1A1 (0.31) | PTGS1SLC7A11 | |
| SCHEMBL2358765 | 0.78 | ALDH1A1 (0.32) | PTGS1SLC7A11 | |
| SCHEMBL2358767 | 0.78 | ALDH1A1 (0.32) | PTGS1SLC7A11 | |
| SCHEMBL11564544 | 0.77 | PTGS1 (0.35) | PTGS1SLC7A11 | |
| SCHEMBL4541471 | 0.76 | ALDH1A1 (0.33) | PTGS1SLC7A11 | |
| SCHEMBL4541470 | 0.76 | ALDH1A1 (0.33) | PTGS1SLC7A11 | |
| SCHEMBL29192552 | 0.75 | GRIK1 (0.40) | PTGS1SLC7A11GRIN2DGRIN3BGRIN1 | |
| SCHEMBL1158205 | 0.74 | ALDH1A1 (0.32) | PTGS1SLC7A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003075901-A2 | USE OF S-SUBSTITUTED L-CRYSTEINE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS | GHISALBERTI CARLO (BR) | 2003-09-18 | — | — | WO | disclosed |